Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A prevalence among injection drug users.

Rebecca Wells1, Dennis Fisher, Andrea Fenaughty

  • 1Section of Chronic Disease Prevention and Health Promotion, Department of Health and Social Services, Juneau, AK, USA.

Clinical Laboratory Science : Journal of the American Society for Medical Technology
|April 19, 2006
PubMed
Summary

Hepatitis A virus (HAV) prevalence was 33% in injection drug users (IDUs). Factors like hepatitis B core antibody status, education, age, and heroin use influenced HAV infection risk. IDUs need hepatitis vaccination and hygiene interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvements in Capacity Among Community Coalitions Receiving Technical Assistance Through the Coalition Check-Up.

Prevention science : the official journal of the Society for Prevention Research·2026
Same author

Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shortening.

Arthritis research & therapy·2026
Same author

Associations between inclusive community coalition leadership and use of evidence-based practices.

American journal of community psychology·2026
Same author

Evidence-based team intervention to reduce diagnostic errors in anaemia and CKD diagnoses in primary care: protocol for a stepped-wedge cluster RCT.

BMJ open·2026
Same author

Improving food system outcomes with beans, peas and pulses: a prospective mapping review of research in the UK.

Public health nutrition·2026
Same author

Acute Pain in Children with Chronic Musculoskeletal Pain: A Prospective Controlled Study of Intensive Interdisciplinary Treatment.

Children (Basel, Switzerland)·2025

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • Hepatitis A virus (HAV) poses a significant health risk, particularly in vulnerable populations.
  • Injection drug users (IDUs) are at increased risk for various infectious diseases due to their lifestyle and potential for exposure.
  • Understanding the specific risk factors for HAV infection within the IDU community is crucial for targeted prevention strategies.

Purpose of the Study:

  • To develop a descriptive model illustrating the association between injection drug use and hepatitis A virus infection.
  • To identify demographic and behavioral factors associated with HAV seroprevalence among injection drug users.

Main Methods:

  • A cohort of 493 injection drug users in Anchorage, Alaska, were enrolled between May 1997 and July 1999.

Related Experiment Videos

  • Participants completed the NIDA Risk Behavior Assessment (RBA), and blood samples were analyzed for antibodies to HAV, hepatitis B core (HBcAB), and hepatitis C.
  • Logistic regression analysis was employed to identify predictors of positive HAV serostatus.

    • Main Results:

    • The overall prevalence of HAV antibodies in the study sample was 33%.
    • Key predictors of HAV infection included positive HBcAB serostatus (OR=3.43), less than high school education (OR=2.05), increased age (OR=1.06 per year), and more frequent heroin injection (OR=1.05 per day).
    • White race was associated with a lower likelihood of HAV infection (OR=0.49) compared to other racial/ethnic groups.

    Conclusions:

    • A comprehensive model incorporating demographic and drug use variables effectively describes HAV prevalence in this IDU sample.
    • Findings underscore the need for targeted interventions, including hepatitis A vaccination and improved hygiene practices, for injection drug users.
    • Further research is recommended to elucidate the relationship between HAV and hepatitis B infection in this population.